Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fox

Showing results (1011-1020 of 1,012) with videos related to

Pageof 102
Sort By:
You have reached the last page of results.This site can display upto 1,012 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2020
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective StrategyAnthony R Mato, Lindsey E Roeker, Ryan Jacobs, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2014
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries, Dorita Avila, Keri N Althoff, et al.
Pageof 102

Showing results (1011-1020 of 1,012) with videos related to

Sort By:
Pageof 102
You have reached the last page of results.This site can display upto 1,012 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2020
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective StrategyAnthony R Mato, Lindsey E Roeker, Ryan Jacobs, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2014
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries, Dorita Avila, Keri N Althoff, et al.
Pageof 102